Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients With Severe Nasal Polyposis
Conditions
Interventions
Benralizumab 30 mg SC + Mometasone Furoate
Matching placebo SC + Mometasone Furoate
Locations
99
United States
Research Site
Birmingham, Alabama, United States
Research Site
Fresno, California, United States
Research Site
Huntington Beach, California, United States
Research Site
La Mesa, California, United States
Research Site
Los Angeles, California, United States
Research Site
Los Angeles, California, United States
Start Date
January 15, 2018
Primary Completion Date
July 31, 2020
Completion Date
July 31, 2020
Last Updated
October 12, 2021
NCT07528820
NCT04157335
NCT06930612
NCT05131958
NCT03979716
NCT04532736
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions